CC
AGN

Carlson Capital’s Allergan plc AGN Stock Holding History

Carlson Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,065,020
Closed -$366M – 268
2020
Q1 		$366M Buy
2,065,020
+436,214
+27% +$82.1M 9.64% 1
2019
Q4 		$311M Buy
1,628,806
+418,806
+35% +$75.6M 5.62% 1
2019
Q3 		$204M Buy
1,210,000
+780,000
+181% +$127M 3.68% 2
2019
Q2 		$72M Buy
+430,000
New +$59.5M 1.09% 13
2017
Q3 		– Sell
-66,341
Closed -$16.1M – 287
2017
Q2 		$16.1M Buy
+66,341
New +$15.6M 0.23% 134
2016
Q2 		– Sell
-96,500
Closed -$25.9M – 346
2016
Q1 		$25.9M Buy
96,500
+56,500
+141% +$16.2M 0.31% 99
2015
Q4 		$12.5M Hold
40,000
– – 0.14% 183
2015
Q3 		$10.9M Sell
40,000
-78,067
-66% -$24M 0.13% 201
2015
Q2 		$35.8M Sell
118,067
-9,128
-7% -$2.72M 0.39% 82
2015
Q1 		$37.9M Buy
127,195
+102,080
+406% +$29.1M 0.42% 73
2014
Q4 		$6.46M Sell
25,115
-43,189
-63% -$10.8M 0.06% 259
2014
Q3 		$16.5M Sell
68,304
-18,886
-22% -$4.23M 0.18% 175
2014
Q2 		$19.4M Sell
87,190
-6,335
-7% -$1.31M 0.21% 150
2014
Q1 		$19.3M Buy
+93,525
New +$18.5M 0.22% 147
2013
Q3 		– Sell
-162,960
Closed -$20.6M – 332
2013
Q2 		$20.6M Buy
+162,960
New +$18.5M 0.25% 135

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Carlson Capital's AGN Position: Q2 2020 in Review

Carlson Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,065,020 shares — an estimated $366M sold.

Carlson Capital first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $366M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Carlson Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Carlson Capital sold 2,065,020 Allergan plc shares in Q2 2020, an estimated $366M.
  • Carlson Capital first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
  • Carlson Capital's Allergan plc position peaked at $366M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Carlson Capital's 13F filing for Q2 2020, filed 14 Aug 2020.